WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Children Attend Event as 'Little Architects' Ahead of Int'l Children's Day in Xi'anChina to Build More LowChina Int'l Big Data Industry Expo 2022 Opens Online in GuizhouNation to Promote Free HPV Vaccinations in More RegionsSmart Health Care Hut Offers Residents Great Convenience in East ChinaMore Graduates Opt to Work in LowerSchools in N China Organize AfterChina Focus: China Makes Historic Achievements in Human Rights ProtectionChina Tops the World in Globally Important Agricultural Heritage SystemsHong Kong, China hold Turkmenistan in FIFA World Cup qualifier
3.12s , 5533.1171875 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,International Image news portal